Methotrexate for gestational choriocarcinoma: a paradigm shift in oncology

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nature reviews. Endocrinology 2023-09, Vol.19 (9), p.501-501
1. Verfasser: Chin, Alfred C.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 501
container_issue 9
container_start_page 501
container_title Nature reviews. Endocrinology
container_volume 19
creator Chin, Alfred C.
description
doi_str_mv 10.1038/s41574-023-00874-9
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2840246086</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2840246086</sourcerecordid><originalsourceid>FETCH-LOGICAL-c326t-11593c34bf9eb4e95166fa93cd312fb92f2dbd6434151c2e87dc0703565867ff3</originalsourceid><addsrcrecordid>eNp9kD1PwzAQhi0EolD4AwwoEgtL4PwRO2FDFZ8qYoHZchy7TZXExU4k-u8xbSkSA5NP9nPv-R6EzjBcYaD5dWA4EywFQlOAPFbFHjrCIivSDKjY39WkGKHjEBYAnDPBDtGICsZzAXCEnl9MP3e9N5-qN4l1PpmZ0Ku-dp1qEj13vnZaeV13rlU3iUqWyquqnrVJmNe2T-oucZ12jZutTtCBVU0wp9tzjN7v794mj-n09eFpcjtNNSW8TzHOCqopK21hSmaKDHNuVbyqKCa2LIglVVlxRuN2WBOTi0qDAJrxLOfCWjpGl5vcpXcfQ_ytbOugTdOozrghSJIzIIxDziN68QdduMHHzdZUDgSDoJEiG0p7F4I3Vi593Sq_khjkt2m5MS2jabk2LYvYdL6NHsrWVLuWH7URoBsgxKduZvzv7H9ivwDdyYhU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2848021073</pqid></control><display><type>article</type><title>Methotrexate for gestational choriocarcinoma: a paradigm shift in oncology</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Chin, Alfred C.</creator><creatorcontrib>Chin, Alfred C.</creatorcontrib><identifier>ISSN: 1759-5029</identifier><identifier>EISSN: 1759-5037</identifier><identifier>DOI: 10.1038/s41574-023-00874-9</identifier><identifier>PMID: 37468700</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>631/67/1059/99 ; 692/4028/67/1059/99 ; Choriocarcinoma ; Choriocarcinoma - drug therapy ; Endocrinology ; Female ; Gestational Trophoblastic Disease - drug therapy ; Humans ; Journal Club ; Medicine ; Medicine &amp; Public Health ; Methotrexate ; Methotrexate - therapeutic use ; Pregnancy ; Uterine Neoplasms - drug therapy</subject><ispartof>Nature reviews. Endocrinology, 2023-09, Vol.19 (9), p.501-501</ispartof><rights>Springer Nature Limited 2023</rights><rights>Springer Nature Limited 2023.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c326t-11593c34bf9eb4e95166fa93cd312fb92f2dbd6434151c2e87dc0703565867ff3</cites><orcidid>0000-0001-6383-2689</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1038/s41574-023-00874-9$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1038/s41574-023-00874-9$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37468700$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chin, Alfred C.</creatorcontrib><title>Methotrexate for gestational choriocarcinoma: a paradigm shift in oncology</title><title>Nature reviews. Endocrinology</title><addtitle>Nat Rev Endocrinol</addtitle><addtitle>Nat Rev Endocrinol</addtitle><subject>631/67/1059/99</subject><subject>692/4028/67/1059/99</subject><subject>Choriocarcinoma</subject><subject>Choriocarcinoma - drug therapy</subject><subject>Endocrinology</subject><subject>Female</subject><subject>Gestational Trophoblastic Disease - drug therapy</subject><subject>Humans</subject><subject>Journal Club</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Methotrexate</subject><subject>Methotrexate - therapeutic use</subject><subject>Pregnancy</subject><subject>Uterine Neoplasms - drug therapy</subject><issn>1759-5029</issn><issn>1759-5037</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp9kD1PwzAQhi0EolD4AwwoEgtL4PwRO2FDFZ8qYoHZchy7TZXExU4k-u8xbSkSA5NP9nPv-R6EzjBcYaD5dWA4EywFQlOAPFbFHjrCIivSDKjY39WkGKHjEBYAnDPBDtGICsZzAXCEnl9MP3e9N5-qN4l1PpmZ0Ku-dp1qEj13vnZaeV13rlU3iUqWyquqnrVJmNe2T-oucZ12jZutTtCBVU0wp9tzjN7v794mj-n09eFpcjtNNSW8TzHOCqopK21hSmaKDHNuVbyqKCa2LIglVVlxRuN2WBOTi0qDAJrxLOfCWjpGl5vcpXcfQ_ytbOugTdOozrghSJIzIIxDziN68QdduMHHzdZUDgSDoJEiG0p7F4I3Vi593Sq_khjkt2m5MS2jabk2LYvYdL6NHsrWVLuWH7URoBsgxKduZvzv7H9ivwDdyYhU</recordid><startdate>20230901</startdate><enddate>20230901</enddate><creator>Chin, Alfred C.</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQGLB</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-6383-2689</orcidid></search><sort><creationdate>20230901</creationdate><title>Methotrexate for gestational choriocarcinoma: a paradigm shift in oncology</title><author>Chin, Alfred C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c326t-11593c34bf9eb4e95166fa93cd312fb92f2dbd6434151c2e87dc0703565867ff3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>631/67/1059/99</topic><topic>692/4028/67/1059/99</topic><topic>Choriocarcinoma</topic><topic>Choriocarcinoma - drug therapy</topic><topic>Endocrinology</topic><topic>Female</topic><topic>Gestational Trophoblastic Disease - drug therapy</topic><topic>Humans</topic><topic>Journal Club</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Methotrexate</topic><topic>Methotrexate - therapeutic use</topic><topic>Pregnancy</topic><topic>Uterine Neoplasms - drug therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chin, Alfred C.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>ProQuest Health &amp; Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health &amp; Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Applied &amp; Life Sciences</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>Nature reviews. Endocrinology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chin, Alfred C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Methotrexate for gestational choriocarcinoma: a paradigm shift in oncology</atitle><jtitle>Nature reviews. Endocrinology</jtitle><stitle>Nat Rev Endocrinol</stitle><addtitle>Nat Rev Endocrinol</addtitle><date>2023-09-01</date><risdate>2023</risdate><volume>19</volume><issue>9</issue><spage>501</spage><epage>501</epage><pages>501-501</pages><issn>1759-5029</issn><eissn>1759-5037</eissn><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>37468700</pmid><doi>10.1038/s41574-023-00874-9</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0001-6383-2689</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1759-5029
ispartof Nature reviews. Endocrinology, 2023-09, Vol.19 (9), p.501-501
issn 1759-5029
1759-5037
language eng
recordid cdi_proquest_miscellaneous_2840246086
source MEDLINE; SpringerLink Journals - AutoHoldings
subjects 631/67/1059/99
692/4028/67/1059/99
Choriocarcinoma
Choriocarcinoma - drug therapy
Endocrinology
Female
Gestational Trophoblastic Disease - drug therapy
Humans
Journal Club
Medicine
Medicine & Public Health
Methotrexate
Methotrexate - therapeutic use
Pregnancy
Uterine Neoplasms - drug therapy
title Methotrexate for gestational choriocarcinoma: a paradigm shift in oncology
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T20%3A31%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Methotrexate%20for%20gestational%20choriocarcinoma:%20a%20paradigm%20shift%20in%20oncology&rft.jtitle=Nature%20reviews.%20Endocrinology&rft.au=Chin,%20Alfred%20C.&rft.date=2023-09-01&rft.volume=19&rft.issue=9&rft.spage=501&rft.epage=501&rft.pages=501-501&rft.issn=1759-5029&rft.eissn=1759-5037&rft_id=info:doi/10.1038/s41574-023-00874-9&rft_dat=%3Cproquest_cross%3E2840246086%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2848021073&rft_id=info:pmid/37468700&rfr_iscdi=true